Tim Wert, director, oncology payer services, Eli Lilly
Glenn Whaley, AVP and controller, ImClone Systems, a subsidiary of Eli Lilly
Matthew Williams, director of commercial development, Biodesix
Paul Windt, senior director, clinical trial management, Regeneron Pharmaceuticals
Todd Winge, vice president of biologics manufacturing, ImClone Systems, a subsidiary of Eli Lilly
Larry Witte, executive vice president of R&D, Kadmon Pharmaceuticals
Liz Yamashita, principal fellow, regulatory CMC strategy, vice president of regulatory CMC and operations, ImClone Systems, a subsidiary of Eli Lilly
Abby Zamora, senior manager, sales operations, Columbia Laboratories
Kristin Furmick Zemanek, director of organizational learning and development, ImClone Systems, a subsidiary of Eli Lilly
Zhenping Zhu, executive vice president, global biologics R&D, Kadmon Pharmaceuticals, president and CEO, Kadmon China
Kenneth Zuerblis, director, Immunomedics
